Valsartan Cancer Lawsuits Consolidated in Multi-District Litigation (MDL) & What it Means to You

Beginning on February 14th, 2019, survivors seeking compensation through class action and product liability lawsuits involving Valsartan will now consolidate into a multi-district litigation, known as an MDL. The MDL will take place in the District of New Jersey before the Honorable Robert B. Kugler. The MDL order will have significant implications on the lawsuits already filed by victims of the harmful Valsartan contaminant, impacting new cases as well as those currently in process. If you are suffering injuries from Valsartan-contaminated medication, here is what you need to know about the new Valsartan litigation. What Is Valsartan? Continue Reading

Read more detail on Recent Medical Malpractice posts –

Last search terms:

Related news:

This entry was posted in Medical malpractice law and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply